Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn Pharmaceutical Investing
Abbott Wins Prestigious Prix Galien USA Award for First-of-its-Kind MitraClip Device Medical Device Investing
Algernon Pharmaceuticals Announces Green Light From Data and Safety Monitoring Board to Continue its Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19 Biotech Investing
Bausch Health's Rifaximin Receives FDA Orphan Designation For Sickle Cell Disease Medical Device Investing
Bausch Health To Reduce Debt By $150 Million Using Cash Generated From Operations Medical Device Investing
AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ in Atopic Dermatitis Biotech Investing
AbbVie Highlights Innovative Research for People with Rheumatic Diseases with New Data at ACR Convergence 2020 Biotech Investing
Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia Biotech Investing
